References:
- Pichler WJ. Immune pathomechanism and classification of drug
hypersensitivity. Allergy. 2019 Aug;74(8):1457-1471.
- Garvey LH, Dewachter P, Hepner DL, Mertes PM, Voltolini S, Clarke R,
Cooke P, Garcez T, Guttormsen AB, Ebo DG, Hopkins PM, Khan DA, Kopac
P, Krøigaard M, Laguna JJ, Marshall S, Platt P, Rose M, Sabato V,
Sadleir P, Savic L, Savic S, Scherer K, Takazawa T, Volcheck GW,
Kolawole H. Management of suspected immediate perioperative allergic
reactions: an international overview and consensus recommendations. Br
J Anaesth. 2019;123(1):e50-e64.
- Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med.
2003;139(8):683-93. Review.
- Blanca-Lopez N, Soriano V, Garcia-Martin E, Canto G, Blanca M.
NSAID-induced reactions: classification, prevalence, impact, and
management strategies. J Asthma Allergy. 2019;12:217-233. Review.
- Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the
United States, 1999-2010: temporal patterns and demographic
associations. J Allergy Clin Immunol. 2014; 134(6):1318-1328.e7.
- Landsteiner K, Jacobs J. Studies on the sensitization of animals with
simple chemical compounds. II. J Exp Med. 1936;64(4):625-39.
- Castells M, Khan DA, Phillips EJ. Penicillin Allergy. N Engl J Med.
2019; 381(24):2338-2351.
- Greim H. Use of covalent binding in risk assessment. Adv Exp Med Biol.
2001;500:715-22. Review.
- Nakayama S, Atsumi R, Takakusa H, Kobayashi Y, Kurihara A, Nagai Y,
Nakai D, Okazaki O. A zone classification system for risk assessment
of idiosyncratic drug toxicity using daily dose and covalent binding.
Drug Metab Dispos. 2009;37(9):1970-7.
- Kepil Özdemir S, Bavbek S. Hypersensitivity reactions to proton-pump
inhibitors: Clinical presentation, diagnosis, and management. Allergy
Asthma Proc. 2020;41(2):e37-e44.
- Brockow K, Ring J. Anaphylaxis to radiographic contrast media. Curr
Opin Allergy Clin Immunol. 2011;11(4):326-31. Review.
- McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, Dong
X.Identification of a mast-cell-specific receptor crucial for
pseudo-allergic drug reactions. Nature. 2015;519(7542):237-41.
- Elsheikh A, Lavergne SN, Castrejon JL, Farrell J, Wang H, Sathish J,
Pichler, WJ, Park BK, Naisbitt DJ. Drug antigenicity, immunogenicity,
and costimulatory signaling: evidence for formation of a functional
antigen through immune cell metabolism. J Immunol.
2010;185(11):6448-60.
- Singh J, Petter RC, Baillie TA, Whitty A. The resurgence of covalent
drugs. Nat Rev Drug Discov. 2011;10(4):307-17. Review.
- Milagre CDF., Luís F, Cabeça LF, Almeida WP, Marsaioli AJ. β-lactam
antibiotics epitope mapping with STD NMR spectroscopy: a study of
drug-human serum albumin interaction. J Braz Chem
Soc. 2012;23(3):403-8.
- Qiu Y, Benet LZ, Burlingame AL. Identification of the hepatic protein
targets of reactive metabolites of acetaminophen in vivo in mice using
two-dimensional gel electrophoresis and mass spectrometry. J Biol
Chem. 1998;273(28):17940-53.
- Meng X, Al-Attar Z, Yaseen FS, Jenkins R, Earnshaw C, Whitaker P,
Peckham D, French NS, Naisbitt DJ, Park BK. Definition of the Nature
and Hapten Threshold of the β-Lactam Antigen Required for T Cell
Activation In Vitro and in Patients. J Immunol.
2017;198(11):4217-4227. Erratum in: J Immunol. 2018; 200(5):1952
- Meng X, Jenkins RE, Berry NG, Maggs JL, Farrell J, Lane CS, Stachulski
AV,French NS, Naisbitt DJ, Pirmohamed M, Park BK. Direct evidence for
the formation of diastereoisomeric benzylpenicilloyl haptens from
benzylpenicillin and benzylpenicillenic acid in patients. J Pharmacol
Exp Ther. 2011;338(3):841-9.
- Vareeckal-Joseph S. The role of haptenation in penicillin and
cephalosporin allergy, doctoral thesis 2018, School of Pharmacy and
Medical Sciences, Division of Health Sciences, Univ. of South
Australia
- de Las Vecillas Sánchez L, Alenazy LA, Garcia-Neuer M, Castells MC.
Drug Hypersensitivity and Desensitizations: Mechanisms and New
Approaches. Int J Mol Sci. 2017;20;18(6):1316.
- Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, Bircher A,
Campi P, Sanz ML, Castells M, Demoly P, Pichler WJ; European Network
of Drug Allergy and the EAACI interest group on drug hypersensitivity.
General considerations on rapid desensitization for drug
hypersensitivity - a consensus statement. Allergy.
2010:65(11):1357-66.
- Mueller UR. Insect sting allergy. Clinical picture, diagnosis and
treatment, Stuttgart: Gustav Fischer, 1990.
- Köhli-Wiesner A, Stahlberger L, Bieli C, Stricker T, Lauener R.
Induction of specific immunotherapy with hymenoptera venoms using
ultrarush regimen in children: safety and tolerance. J Allergy
(Cairo). 2012;2012:790910.
- Klein L, Robey EA, Hsieh CS. Central CD4(+) T cell tolerance: deletion
versus regulatory T cell differentiation. Nat Rev Immunol.
2019;19(1):7-18.
- Wüthrich B, Schindler C, Leuenberger P, Ackermann-Liebrich U.
Prevalence of atopy and pollinosis in the adult population of
Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung
Diseases in Adults. Int Arch Allergy Immunol. 1995;106(2):149-56.
- Arquint O, Helbling A, Crameri R, Ferreira F, Breitenbach M, Pichler
WJ. Reduced in vivo allergenicity of Bet v 1d isoform, a natural
component of birchpollen. J Allergy Clin Immunol. 1999
Dec;104(6):1239-43.
- Buters JT, Weichenmeier I, Ochs S, Pusch G, Kreyling W, Boere AJ,
Schober W, Behrendt H. The allergen Bet v 1 in fractions of ambient
air deviates from birch pollen counts. Allergy. 2010 Jul;65(7):850-8
- Schnyder B, Burkhart C, Schnyder-Frutig K, von Greyerz S, Naisbitt DJ,
Pirmohamed M, Park BK, Pichler WJ. Recognition of sulfamethoxazole and
its reactive metabolites by drug-specific CD4+ T cells from allergic
individuals. J Immunol. 2000;164(12):6647-54.
- Haddi E, Charpin D, Tafforeau M, Kulling G, Lanteaume A, Kleisbauer
JP,Vervloet D. Atopy and systemic reactions to drugs. Allergy.
1990;45(3):236-9.
- Hellman LT, Akula S, Thorpe M, Fu Z. Tracing the Origins of IgE, Mast
Cells,and Allergies by Studies of Wild Animals. Front Immunol.
2017;19;8:1749.